Utilization of Antitumor Necrosis Factor Biologics in Very Early Onset Inflammatory Bowel Disease: A Multicenter Retrospective Cohort Study From North America
暂无分享,去创建一个
Lina Karam | A. Griffiths | J. Kelsen | N. LeLeiko | S. Snapper | J. Galanko | A. Goyal | E. Benchimol | M. Kappelman | M. Heyman | J. Rosh | M. Stephens | J. Hyams | J. Noe | J. V. van Limbergen | M. Pfefferkorn | A. Muise | H. Pappa | K. Benkov | M. Deneau | A. Guerrerio | L. Siebold | R. Maltz | Ying Lu | E. Crowley | J. Strople | K. Fiedler | Dedrick E. Moulton | M. Stahl | Basavaraj Kerur | Razan H Alkhouri | Razan H. Alkhouri | Michael C. Stephens
[1] M. Kattan,et al. Differences in Biologic Utilization and Surgery Rates in Pediatric and Adult Crohn's Disease: Results From a Large Electronic Medical Record-derived Cohort. , 2020, Inflammatory bowel diseases.
[2] Lina Karam,et al. Natural History of Very Early Onset Inflammatory Bowel Disease in North America: A Retrospective Cohort Study. , 2020, Inflammatory bowel diseases.
[3] J. Colombel,et al. Systematic review and meta‐analysis: efficacy and safety of early biologic treatment in adult and paediatric patients with Crohn’s disease , 2020, Alimentary pharmacology & therapeutics.
[4] R. Stanley,et al. Off-Label Prescribing in Children Remains High: A Call for Prioritized Research , 2019, Pediatrics.
[5] Noor B. Dawany,et al. The Unique Disease Course of Children with Very Early onset-Inflammatory Bowel Disease. , 2019, Inflammatory bowel diseases.
[6] Paul A. Harris,et al. The REDCap consortium: Building an international community of software platform partners , 2019, J. Biomed. Informatics.
[7] R. Ardy,et al. Early‐onset inflammatory bowel disease as a model disease to identify key regulators of immune homeostasis mechanisms , 2018, Immunological reviews.
[8] A. Bousvaros,et al. Pediatric Inflammatory Bowel Disease Clinical Innovations Meeting of the Crohn's & Colitis Foundation: Charting the Future of Pediatric IBD. , 2018, Inflammatory bowel diseases.
[9] C. Moran. Very early onset inflammatory bowel disease. , 2017, Seminars in pediatric surgery.
[10] D. Tanyingoh,et al. Trends in Epidemiology of Pediatric Inflammatory Bowel Disease in Canada: Distributed Network Analysis of Multiple Population-Based Provincial Health Administrative Databases , 2017, The American Journal of Gastroenterology.
[11] N. Sebire,et al. Phenotypic and Genotypic Characterisation of Inflammatory Bowel Disease Presenting Before the Age of 2 years , 2017, Journal of Crohn's & colitis.
[12] J. Machan,et al. Durability of Infliximab Is Associated With Disease Extent in Children With Inflammatory Bowel Disease , 2016, Journal of pediatric gastroenterology and nutrition.
[13] B. Nørgård,et al. Use of Anti-TNFα Agents and Time to First-time Surgery in Paediatric Patients with Ulcerative Colitis and Crohn's Disease. , 2016, Journal of Crohn's & colitis.
[14] A. Griffiths,et al. Clinical Presentation and Five-Year Therapeutic Management of Very Early-Onset Inflammatory Bowel Disease in a Large North American Cohort. , 2015, The Journal of pediatrics.
[15] C. Klein,et al. The diagnostic approach to monogenic very early onset inflammatory bowel disease. , 2014, Gastroenterology.
[16] E. Miele,et al. Phenotype and Disease Course of Early-onset Pediatric Inflammatory Bowel Disease , 2014, Inflammatory bowel diseases.
[17] J. Kelsen,et al. Infliximab Therapy in Pediatric Patients 7 Years of Age and Younger , 2014, Journal of pediatric gastroenterology and nutrition.
[18] S. Snapper,et al. The age of gene discovery in very early onset inflammatory bowel disease. , 2012, Gastroenterology.
[19] David C Wilson,et al. Pediatric modification of the Montreal classification for inflammatory bowel disease: The Paris classification , 2011, Inflammatory bowel diseases.
[20] P. Rutgeerts,et al. Infliximab, azathioprine, or combination therapy for Crohn's disease. , 2010, The New England journal of medicine.
[21] O. Goulet,et al. Characteristics of Inflammatory Bowel Disease With Onset During the First Year of Life , 2006, Journal of pediatric gastroenterology and nutrition.